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Abstract
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Introduction
Intravenous vancomycin therapy typically starts with a loading dose followed by a maintenance dose 12 to 24 hours later. In the acute
hospital setting, this often results in doses being administered in the middle of the night, which is impractical for both patients and
staff. This audit examined current practice and developed new guidelines to support greater flexibility in the timing of the first
maintenance dose.  
Methods
Data recording forms used by pharmacists to support the therapeutic drug monitoring of vancomycin were collected from two
hospital sites over six weeks. Forms containing at least two vancomycin concentrations were selected and the time of administration
of the first maintenance dose was recorded. Individual vancomycin pharmacokinetic parameter estimates were obtained using MAP
Bayesian analysis then used to predict vancomycin concentrations 6, 8, 10, 12 and 14 hours after a banded loading dose and 20
mg/kg (capped at 3000 mg). Predicted concentrations were compared with a target range of 10 – 20 mg/L.     
Results
Data were obtained from 49 patients with a mean (SD) age of 63.1 (16.7) years and weight 80.1 (27.6) kg. In all patients, creatinine
clearance estimates were >40 mL/min and, according to current practice guidelines, all patients required 12 hourly maintenance
dosing. The time recorded for the administration of the first maintenance dose was between 11 pm and 7 am in 30 (61%) of these
patients. In 14 patients (29%), the first maintenance dose was administered >12 hours after loading. The target range was achieved
with banded doses (20 mg/kg) in 65% (71%) of concentrations at 6 hours, 74% (84%) at 8 hours, 57% (67%) at 10 hours, 53% (55%)
at 12 hours and 39% (43%) at 14 hours.    
Conclusion
This audit has shown that current practice results in a high proportion of vancomycin maintenance doses being administered at
impractical times. Allowing a more flexible time window of 6-12 hours after the loading dose for administration of the first vancomycin
maintenance dose could help to alleviate this problem and reduce the risk of early subtherapeutic vancomycin trough concentrations.  
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Introduction
Vancomycin is a glycopeptide antibiotic that is used in the
treatment of serious infections, including methicillin-resistant
Staphylococcus aureus (MRSA). Although studies have found
that clinical and bacterial response to vancomycin is best related
to the daily area under the curve to MIC ratio (AUC/MIC),1 current
practice is to monitor trough concentrations for efficacy and
toxicity. The target range recommended by the Scottish
Antimicrobial Prescribing Group (SAPG) is 10 – 20 mg/L, which
is increased to 15 – 20 mg/L for patients with severe or deep-
seated infections.2
Current SAPG vancomycin dosage guidelines recommend a
banded loading dose based on weight (around 15 – 25 mg/kg)
followed by a maintenance dose based on renal function.2 As
the guidelines state that the timing of the first maintenance dose
should reflect the maintenance dosage interval, the majority of
patients receive their first maintenance dose 12 or 24 hours
after the start of their loading dose. Observational data and
feedback comments from staff suggested that these guidelines,
particularly for 12 hourly regimens, often led to dosage
regimens that required vancomycin infusions to be set up
overnight. This was challenging for staff and disturbing for
patients. Furthermore, anecdotal observations from pharmacy
and medical staff suggested that the first measured trough
concentrations of vancomycin were often below the target
range of 10 to 20 mg/L. 
This study aimed to identify whether following current
vancomycin guidelines resulted in a high proportion of
maintenance doses being initiated at impractical times, to
quantify the risk of low trough concentrations and to determine
whether current guidance on the timing of the first maintenance
dose could be modified to increase flexibility and the
achievement of target trough concentrations.
Methods
Patients and data collection 
A standardised data collection form was devised, piloted using
data from five patients then finalised. Data were collected
prospectively and retrospectively from medical and surgical
wards across two hospital sites over a period of six weeks.
Patients were selected for inclusion if their data were recorded
on the local vancomycin prescribing and administration chart
and at least two vancomycin concentration measurements
were available. The following data were collected for each
patient: age; weight; sex; creatinine concentration; vancomycin
doses, duration of infusion and administration times;
vancomycin concentration measurements and sampling times.
In addition, the clock times when the loading dose and the first
maintenance were administered were recorded.
Pharmacokinetic analysis  
The clinical characteristics of each patient and their vancomycin
dose and concentration data were entered into a MAP
Bayesian pharmacokinetic package, OPT.3 Initial estimates of
vancomycin clearance (CL) and volume of distribution (V) were
obtained using the Matzke equations4 assuming a one-
compartment model. Creatinine clearance was estimated using
the Cockcroft Gault equation.5 OPT was then used to generate
individual estimates of vancomycin CL and V for each patient
by combining these initial estimates with the observed
concentration data. Any patient whose measured concentrations
varied by more than 20% from those predicted using the
individual parameter estimates was removed from further
analysis. This was done to avoid confounding the results with
data from patients with rapidly changing renal function or errors
in dose or sample time. The individual pharmacokinetic
parameter values were then used to predict vancomycin
concentrations at the time the first maintenance dose was
administered and at 6, 8, 10, 12 and 14 hours after the start of
the correct banded loading dose and after a dose of 20 mg/kg
(capped at 3000 mg). The percentages of predicted vancomycin
concentrations within the 10 - 20 mg/L target range were then
determined for each time point.  
Results
A total of 59 patients were initially identified, of which 10 were
removed due to poor fits of their data and uncertainty regarding
the accuracy of the dose or sample times. The 49 patients
included in the final data set comprised 27 males and 22
females. Patients had a mean (SD) age of 63.1 (16.7) years,
weight 80.1 (27.6) kg and creatinine concentration 71 (18)
µmol/L. Estimated creatinine clearance had a mean (SD) of 91.7
(42.7) mL/min and ranged from 40 to 240 mL/min. All patients
received 12 hourly maintenance doses of vancomycin.  
Of the 49 patients, 35 (71%) were treated according to the
SAPG vancomycin guidelines2 and were prescribed appropriate
loading doses, maintenance doses and maintenance dosage
intervals. Loading doses ranged from 750 mg to 2000 mg, (8.1
– 28.8 mg/kg). Five patients (10%) received the wrong loading
dose, which was too high in 4 patients and too low in one
patient. The maintenance dose was incorrect for 11 patients
(22%); 6 received a dose that was too low for their estimated
renal function and 5 a dose that was too high. The dosage
interval was incorrect for one patient, who was prescribed 24
hourly dosing instead of 12 hourly dosing. It was found that 30
patients (61%) had their first maintenance dose administered
between the hours of 11 pm and 7 am. These dose
administration times were generally continued for the duration
of the vancomycin treatment.
The first maintenance dose was administered at a mean (SD) of
12.8 (1.7) hours after the loading dose. Figure 1 shows the
predicted vancomycin concentrations at the actual times
patients received their first maintenance dose after loading,
based on their individual pharmacokinetic parameter estimates
and their loading doses. In summary, 35 (71%) patients
received their first vancomycin maintenance dose between 11
and 13 hours after the loading dose, 13 (29%) more 13 hours
after loading and 1 less than 11 hours after loading. Predicted
trough concentrations were within the target range in 27
patients (55%), above 20 mg/L in 2 (4.1%) patients and below
10 mg/L in 20 (41%) patients. 
Figure 2 shows the predicted vancomycin concentrations at
various times after the banded loading dose and Table 1
summarises the percentages of concentrations within the target
range at these times based on both the banded loading dose
and 20 mg/kg. The results show that the optimum time for
patients to receive their first maintenance dose is 6-8 hours
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Figure 1: Predicted vancomycin trough concentrations at the times the first maintenance dose 
was administered. The solid lines indicate the target range of 10-20 mg/L.      
Figure 2: Predicted vancomycin concentrations at various times after a weight-banded loading dose.2
The solid lines indicate the target range. 
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after the loading dose, which is associated with 65-74% of
concentrations being within the target range with the banded
loading dose and 71-84% with 20 mg/kg. Giving the first
maintenance dose 14 hours after the loading dose was the
worst option, with only 39% of patients within the target range
and 57% below 10 mg/L. 
Discussion
This audit was conducted to assess whether anecdotal
concerns about vancomycin therapy were justified and, if so,
whether guidelines could be modified to improve staff and
patient convenience and reduce the risk of underdosing. Since
almost two-thirds of patients (61%) received their first
maintenance dose of vancomycin between the hours of 11pm
and 7am, the study confirmed that patients often receive
vancomycin doses at times that are inconvenient to staff and
disturb patients overnight. These issues arise because
decisions to start vancomycin are often made in the late
morning or early afternoon and loading doses are therefore
administered after midday. The SAPG guidelines2 currently
recommend giving the first maintenance dose at the normal
dosage interval, which is typically 12 hours. Consequently,
patients are routinely prescribed dosage regimens that require
overnight dosing throughout the course of vancomycin therapy.
A second concern was that after loading, trough concentrations
were often below the target minimum value. As trough
concentrations are not routinely measured after a loading dose,
for the purposes of this study, troughs were predicted using
pharmacokinetic parameters derived from an individual analysis
of data collected from each patient. To reduce the impact of the
population model on these predictions, only patients who had
at least two concentration measurements and a good fit of their
data were included in the analysis. Consequently, higher
variability is likely in routine clinical practice. 
The results demonstrated that only 52% of patients were likely
to have a satisfactory vancomycin trough at the actual time they
received their first maintenance dose and even if the next dose
had been given at exactly 12 hours after the correct loading
dose, this value only increased to 53%. This may partly reflect
the use of loading doses banded within weight ranges rather
than a mg/kg approach, which was done to simplify the dose
calculation and preparation of the infusion.2 However, using a
20 mg/kg loading dose achieved similar results. Furthermore, a
recent systemic review has shown that although starting
vancomycin therapy with a weight related loading dose
significantly increased the likelihood of achieving target trough
concentrations, loading doses did not consistently achieve
therapeutic concentrations.6 A potential solution to this problem
is to give a higher loading dose. Rosini et al7 found that
increasing the loading dose from 15 to 30 mg/kg increased the
percentage of patients with initial 12 hour troughs above 10
mg/L from 15% to 80%. However, some clinicians expressed
concerns that doses above 25 mg/kg might lead to a higher risk
of nephrotoxicity. In any case, this approach would not solve the
problem of overnight antibiotic administration.
An alternative approach would be to allow more flexibility in the
time interval between administration of the loading and first
maintenance doses. This is similar to the concept of “multiple
loading doses” proposed by Denetclaw et al,8 who suggested
giving 15 mg/kg every 6, 8 or 12 hours over the first 24 hours
of therapy, according to renal function. The present study used
a higher initial loading dose and focused on the timing of the
first maintenance dose only. The results demonstrated that
troughs above 10 mg/L were more likely if the first maintenance
dose is given 6 or 8 hours after the loading dose and that there
was a low incidence of concentrations above 25 mg/L (6% at 6
hours post dose). Delaying the next dose beyond 12 hours after
loading gave the worst results. Subsequent maintenance doses
would then be given according to the guidelines (usually 12 or
24 hourly) until the dosage interval was confirmed or modified
according to measured concentrations. The advantage of this
approach is that it allows flexibility in dosing times. If a patient is
given a loading dose at 2 pm, they can start regular
maintenance therapy at 8 pm or 10 pm rather than having to
wait till 2 am. It would be prudent to re-audit practice if any
changes are made as a result of these findings.  Further
research would be welcome to confirm the findings and to
assess any unintended consequences e.g. impact on
nephrotoxicity or ototoxicity.
Time Percentage of vancomycin concentrations within range
after 
loading < 10 mg/L 10 – 20 mg/L 20 – 25 mg/L >25 mg/L
Hours Banded 20 mg/kg Banded 20 mg/kg Banded 20 mg/kg Banded 20 mg/kg
6 2 0 65 71 27 27 6 2
8 12 6 74 84 12 10 2 0
10 35 27 57 67 8 6 0 0
12 43 39 53 55 4 6 0 0
14 57 51 39 43 4 6 0 0
Table 1: Percentage of patients whose predicted vancomycin concentrations were within various 
ranges at different times after the start of a banded or 20 mg/kg loading dose. 
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Conclusion
The predicted concentrations observed in this audit
demonstrate that current practice within the acute hospital
setting results in a high proportion of vancomycin maintenance
doses being administered at impractical times and risks early
subtherapeutic trough concentrations. To reduce this risk and
to reduce disruption to patients and staff, vancomycin dosage
guidelines could be modified to recommend that the first
maintenance dose is administered 6 – 12 hours after the start
of the loading infusion. 
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